It is known that the use of a cardiopulmonary bypass (CPB) during cardiac surgery leads to leukocyte activation and may, among other causes, induce organ dysfunction due to increased leukocyte recruitment into different organs. In our patients pathophysiologically severs SIRS, uncontrolled CPB induced inflammation, chylomicrons and very low density lipoproteins (VLDL) or immune complex have been shown to develop immune dependent agglutination by C-reactive proteins in cardiopulmonary bypass, which could result in vascular occlusion and resultant infarction.
INTRODUCTION
Socha found that during CBP, phospholipase A2 degrades arachidonic acid, leading to inflammatory mediators such as leukotrienes, prostaglandins and thromboxanes. The action of these substances triggers adhesion and neutrophil activation, vasoconstriction, tissue injury, platelet aggregation and the ischaemic organ change (1) . The differential diagnosis can be divided into three categories: emboli from the cardiac and arterial system, acquired hypercoagulability disorders and syndromes which lead to peripheral vascular pathology (2) .
CASE REPORT
A 45 years-old woman secondary to rheumatic fever and aortic regurgitation was scheduled for AVR. Pre-operative echocardiography revealed severe aortic regurgitation. She denied any cerebral symptoms including headache, dizziness, transient ischaemic attacks or strokes on past medical history, the patient was found to be fully conscious, alert and oriented with stable vital signs. The blood pressure was 110/80 mmHg and diastolic murmur was audible over mitral area. The physical exam revealed intact cranial nerves, motor power and sensation. There was no evidence of vasculitis such as Osler's nodes, Jane way pad, palmer erythema or cyanosis of fingers. The blood investigation showed an erythrocyte sedimentation rate (ESR) of 4 mm with no leukocytosis (WBC = 10.000 mm 3 ). The electrolytes and kidney and liver function were within normal limits. The chest X-ray was normal. Electrocardiogram (EKG) showed no change. The patient scheduled for re operative aortic valve replacement.
Intra operatively, the aortic valve was tricuspid and was not calcified. The wall of the aorta in the sinus area appeared thin, but there was no root dilatation or wall calcification. A standard cardiopulmonary bypass (CPB) with bicaval cannulation was initiated, and cold cardioplegia was performed for myocardial protection after aortic cross-clamping. The aortic valve was Presence of four or more risk factors should be taken as presumptive evidence of CCE. These risk factors that were not found in our patients include atherosclerotic plaque, hypertension, thrombolitic therapy male sex, smoking, hypercholesterolaemia, diabetes and resuscitation (4). The pathognomic pathologic sign of CCE that was not seen in our patient was neddle shaped cleft in arteriole wall (5) . Some studies found that however, various treatment strategies have been tested to reduce the severity of the systemic inflammation induced by CPB and to improve the treatment, including anti-inflammatory drugs, novel components of the CPB, and new surgical techniques, or anesthetic drugs or technique but no single strategy has been proven effective yet some of these drugs were evaluated in presiding studies (6) (7) (8) . Production of humoral inflammatory mediators and priming of neutrophils by exposure to the CPB apparatus enables a 'post-pump' syndrome characterized by a systemic and decreased serum IL-10 levels are associated with increased organ dysfunction (12) .
CONCLUSION
The tremendous effect of the inflammatory response to ischaemia-reperfusion and the use of CPB indicate the need for measures that might if not inhibit it at least mitigate it. Thus, the control of risk factors, the reduction of ischaemic cardiovascular events, technical training for off-pump surgery, as well as advances in anti-inflammatory therapy, are measures to be reinforced while research should be encouraged so that these objectives are achieved. 
